IL133224A0 - Ancrod specific monoclonal antibodies antibody fragments mixtures or derivatives thereof and use of the same - Google Patents

Ancrod specific monoclonal antibodies antibody fragments mixtures or derivatives thereof and use of the same

Info

Publication number
IL133224A0
IL133224A0 IL13322498A IL13322498A IL133224A0 IL 133224 A0 IL133224 A0 IL 133224A0 IL 13322498 A IL13322498 A IL 13322498A IL 13322498 A IL13322498 A IL 13322498A IL 133224 A0 IL133224 A0 IL 133224A0
Authority
IL
Israel
Prior art keywords
ancrod
mixtures
derivatives
same
monoclonal antibodies
Prior art date
Application number
IL13322498A
Other languages
English (en)
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of IL133224A0 publication Critical patent/IL133224A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL13322498A 1997-07-10 1998-06-23 Ancrod specific monoclonal antibodies antibody fragments mixtures or derivatives thereof and use of the same IL133224A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19729544A DE19729544A1 (de) 1997-07-10 1997-07-10 Ancrod spezifische monoklonale Antikörper, Antikörperfragmente, deren Mischung oder Derivate und deren Verwendung
PCT/EP1998/003834 WO1999002564A2 (de) 1997-07-10 1998-06-23 Ancrod spezifische monoklonale antikörper, antikörperfragmente, deren mischungen oder derivate und deren verwendung

Publications (1)

Publication Number Publication Date
IL133224A0 true IL133224A0 (en) 2001-03-19

Family

ID=7835268

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13322498A IL133224A0 (en) 1997-07-10 1998-06-23 Ancrod specific monoclonal antibodies antibody fragments mixtures or derivatives thereof and use of the same

Country Status (14)

Country Link
US (1) US6365155B1 (xx)
EP (1) EP1000087A2 (xx)
JP (1) JP2002511880A (xx)
KR (1) KR20010021649A (xx)
CN (1) CN1262690A (xx)
AU (1) AU748841B2 (xx)
BR (1) BR9810574A (xx)
CA (1) CA2295218A1 (xx)
CZ (1) CZ297216B6 (xx)
DE (1) DE19729544A1 (xx)
IL (1) IL133224A0 (xx)
NO (1) NO20000079L (xx)
WO (1) WO1999002564A2 (xx)
ZA (1) ZA986064B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI513466B (zh) * 2010-01-20 2015-12-21 Boehringer Ingelheim Int 抗凝血劑解毒劑

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3841736A1 (de) 1988-12-10 1990-07-05 Basf Ag Ancrod-proteine, ihre herstellung und verwendung
CA2015127A1 (en) * 1989-04-26 1990-10-26 John G. Gray, Jr. Novel dna sequences which encode ancrod-like polypeptides and compositions comprising the expression products thereof
EP0556906B1 (en) * 1992-02-17 1996-05-22 Akzo Nobel N.V. Calibrator and use thereof in an immuno-assay
US5523292A (en) * 1992-10-14 1996-06-04 Schwartz; Robert Method of preventing restenosis following coronary angioplasty

Also Published As

Publication number Publication date
CZ297216B6 (cs) 2006-10-11
JP2002511880A (ja) 2002-04-16
BR9810574A (pt) 2000-09-19
NO20000079D0 (no) 2000-01-07
AU748841B2 (en) 2002-06-13
CZ200057A3 (cs) 2000-05-17
KR20010021649A (ko) 2001-03-15
US6365155B1 (en) 2002-04-02
DE19729544A1 (de) 1999-01-14
EP1000087A2 (de) 2000-05-17
NO20000079L (no) 2000-03-07
WO1999002564A3 (de) 1999-04-01
CA2295218A1 (en) 1999-01-21
ZA986064B (en) 2000-01-10
CN1262690A (zh) 2000-08-09
WO1999002564A2 (de) 1999-01-21
AU8540698A (en) 1999-02-08

Similar Documents

Publication Publication Date Title
EP1071458A4 (en) HUMANIZED ANTIBODIES AND ITS USES
AU5665696A (en) Novel methods for the assay of troponin i and t and complexe s of troponin i and t and selection of antibodies for use in immunoassays
PL314908A1 (en) Humanised antibodies and their application
EP0692536A3 (en) Protein that induces interferon gamma production and monoclonal antibodies against it
HU9503638D0 (en) Anti-alpha-v-integrin monoclonal antibody
IL128406A0 (en) Monoclonal antibodies
EP0871393A4 (en) IN SITU MUTUAL DETECTION OF ANTIGENS
EP0870826A4 (en) NEW PROTEINS AND MONOCLONAL ANTIBODIES AGAINST THESE
IL147517A0 (en) Monoclonal antibodies and immunoassay utilizing the same
ID26136A (id) Komposisi untuk mengisi bahan-bahan berpori pengolahan dan penggunaan daripadanya
EP0805161A4 (en) PROTEIN BINDING (1-3) -BETA-D-GLUCANE, PROTEIN RECOGNIZING ANTIBODIES AND USE OF PROTEIN AND ANTIBODY
AU7422496A (en) NM03 antibody materials and methods
AU1448295A (en) Assay employing both protein and antibody
HUP9904199A3 (en) Anti-p53 single-chain antibody fragments and their uses
IL129323A0 (en) Assay for the detection of antibodies against p53
AU1538497A (en) Anti-gp46 antibodies and fragments thereof and their use
IL116228A0 (en) Monoclonal antibody fragments and pharmaceutical compositions containing them
EP0812859A4 (en) MONOCLONAL ANTIBODIES, ANTI COMPLEX "Xa. TFPI" AND ITS USE
EP0909278A4 (en) IMMUNOGLOBULIN G LINKED TO NEPHROPATHY AND ANTIBODIES AGAINST IT
IL109232A0 (en) Human monoclonal antibodies and processes and materials for making such antibodies
IL133224A0 (en) Ancrod specific monoclonal antibodies antibody fragments mixtures or derivatives thereof and use of the same
AU3257399A (en) Monoclonal antibodies esm-1 protein specific, and use of said antibodies for detecting esm-1 protein
HUP0003029A3 (en) Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same
GB9718911D0 (en) Monoclonal antibodies
GB9721432D0 (en) Improved production of antibodies through the use of antigen antibody complexes